Background: Although the Papanicolaou (Pap) smear was originally designed to detect premalignant cervical lesions and cancer, it has become apparent that malignant cells from extrauterine primaries may also appear in the smears. Here, we report a case of a serous borderline tumor (SBT) of the ovary that was detected by a conventional Pap smear. Case Report: In a 34-year-old woman, who was operated on for a left borderline ovarian tumor 2 years ago, glandular dysplasia was discovered in a Pap smear screening. The Pap smear showed a large number of atypical glandular cells forming 3-dimensional papillary clusters. The cell clusters were enlarged and had variably sized round or oval nuclei. The background was clean, and this finding pointed to the noncervical origin of the malignant cells. A right ovarian cystic mass was discovered and a laparotomy performed. A histologic examination of the ovarian mass revealed a SBT of the ovary. Conclusion: This case illustrates the value of the Pap smear in discovering unsuspected extrauterine malignancies, including SBTs of the ovary.

Clement PB, Young RH: Atlas of Gynecologic Surgical Pathology. Philadelphia, Saunders, 2000, pp 304–317.
Kurman RJ: Blaustein’s Pathology of the Female Genital Tract. Berlin, Springer, 2002, pp 810–831.
Tavassoli F, Devilee P: Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Lyon, IARC Press, 2003, pp 117–124.
Olsen TG, Nycum LR, Graham RL, Alagoz T: Primary peritoneal carcinoma presenting on routine Papanicolaou smear. Gynecol Oncol 2000;78:71–73.
Smith JHF: Psammoma bodies in cervical smears: sifting the grains of sand. Cytopathology 2007;18:140–142.
Qizilbash AH: Ovarian carcinoma identified by psammoma bodies in the cervicovaginal and endometrial smears. Can Med Assoc J 1974;19:185–186.
Huijssoon A, Sastrowijoto P, Harmsel B: Papillary adenocarcinoma of the ovary presenting in a PAP-smear. Acta Obstet Gynecol Scand 2001;80:659–660.
Dance EF, Fullmer CD: Cervico-vaginal smears. Acta Cytol 1970;14:187–191.
Benson PA: Psammoma bodies found in cervico-vaginal smears. Case report. Acta Cytol 1973;17:64–66.
Qazi FM, Geisinger KR, Barrett RJ, Hopkins MB, Holleman IL: Cervicovaginal psammoma bodies: the initial presentation of the ovarian borderline tumor. Arch Pathol Lab Med 1988;112:564–566.
Ahsan S, Manyonda I, Spencer T: Psammoma bodies in a cervical smear in association with borderline ovarian epithelial malignancy. J Pak Med Assoc 1998;48:52–53.
Nicklin JL, Perrin L, Obermair A, et al: The significance of psammoma bodies on cervical cytology smears. Gynecol Oncol 2001;83:6–9.
Athavale RD, Chia KV: Psammoma bodies on postmenopausal cervical smear – a rare sinister finding. J Obstet Gynaecol 2002;22:328–329.
Zhang Y, Selvaggi SM: Significance of psammoma bodies on a cervical sample from an asymptomatic woman. Diagn Cytopathol 2003;29:339–340.
Nwanodi O, Choi C, Khulpateea N: Cervicovaginal cytology and diagnosis of ovarian or peritoneal cancer: a case report and literature review. Arch Gynecol Obstet 2008;277:171–174.
Frech HC: Adenocarcinoma of the ovary diagnosed by vaginal smear. Am J Obstet Gynecol 1949;57:802–804.
Koss LG: Diagnostic Cytology and Its Histopathologic Bases. Philadelphia, Lippincott, 1961, p 152.
Differding JT: Psammoma bodies in a vaginal smear. Acta Cytol 1967; 11:199–201.
Fadare O, Chacho M, Parkash V: Psammoma bodies in cervicovaginal smears: significance and practical implications for diagnostic cytopathology. Adv Anat Pathol 2004;11:250–261.
Jenkins DM, Goulden R: Psammoma bodies in cervical cytology smears. Acta Cytol 1977;21:112–113.
Kirkland N, Hardy N: Psammoma bodies found in cervicovaginal smears. A case report. Acta Cytol 1979;23:131–133.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.